Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles

• Status: Recruiting
• Trial end date: 2022-09-21
• Target enrollment: 0
• Participant gender: Female

Summary

This study is a randomized controlled clinical trial to compare the pregnancy outcomes of infertile women with frozen embryo transfer. The study population in frozen embryo transfer cycles receive three doses of human chorionic gonadotropin (HCG) to recognize the effectiveness of HCG on pregnancy outcomes in Reproductive Biomedicine Research Center, Royan institute, Tehran Iran.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Royan Institute
• Treatments: Chorionic Gonadotropin

Criteria

Inclusion Criteria:

Infertile women candidates for frozen embryo transfer Age 20-40 years Body Mass Index under than 30 Kg/m2 Having at least three good quality embryos

Exclusion Criteria:

Women with hematologic and autoimmune disorders Couples with chromosomal and genetic abnormalities Women with uterine anomalies Women with uterine and ovaries surgical history Women with endometriosis and adenomyosis Women with hydrosalpinx Women with uterine fibroids Women with history of recurrent abortion or recurrent implantation failure Severe male factor infertility (azoospermia) Embryo donation cycle Endometrial thickness less than 8 millimeter on the day of embryo transfer